GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbury Ltd (NSE:WANBURY) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Wanbury (NSE:WANBURY) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 28, 2025)


View and export this data going back to 2007. Start your Free Trial

What is Wanbury Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Wanbury's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Wanbury's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Wanbury's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wanbury's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wanbury's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Wanbury's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Wanbury  (NSE:WANBURY) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Wanbury Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Wanbury's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Wanbury Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbury Ltd (NSE:WANBURY) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
BOM:539997 BOM:506414 BOM:506260 BOM:541096 BOM:540737 BOM:531633 BOM:524500 BOM:532408 BOM:530199 BOM:524632 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
524212:India
Address
BSEL Techpark, B Wing, 10th Floor, Sector 30-A, Opposite Vashi Railway Station, Vashi, Navi Mumbai, MH, IND, 400703
Website
https://www.wanbury.com
Wanbury Ltd is engaged in the business of pharmaceutical and related activities including research. Some of the company products are Cpink 50mg table, Rabiplus capsules, Folinine softule, etc. The company has one segment of activity namely Pharmaceuticals. It generates revenue from a contract with customers from the sale of manufactured and traded goods. Geographically, key revenue is generated from outside India.

Wanbury Headlines

No Headlines